Favorable Effects of Tacrolimus Monotherapy on Myasthenia Gravis Patients

Background and Purpose: Tacrolimus (TAC) has been proven to be a rapid-acting, steroid-sparing agent for myasthenia gravis (MG) therapy. However, evidence related to the effectiveness of TAC alone is rare. Therefore, this study was performed to investigate the effect of TAC monotherapy in MG patient...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Neurol
Hoofdauteurs: Fan, Zhirong, Li, Zunbo, Shen, Faxiu, Zhang, Xueping, Lei, Lin, Su, Shengyao, Lu, Yan, Di, Li, Wang, Min, Xu, Min, Da, Yuwei
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2020
Onderwerpen:
Neurology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7652845/
https://ncbi.nlm.nih.gov/pubmed/33193063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.594152
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items